Laser Immunotherapy: A Potential Treatment Modality for Keratinocyte Carcinoma

Area of Science:

• Oncology
• Immunology
• Dermatology

Background:

• Immunotherapy is a breakthrough in cancer treatment, recently extended to keratinocyte carcinoma (KC).
• Systemic immunotherapy for KC has limitations due to side effects, while topical treatments are restricted to superficial lesions.
• Laser therapy has evolved for KC treatment, including immune modulation.

Purpose of the Study:

• To review the current status of KC immunotherapy.
• To discuss immune activation following laser monotherapy and laser immunotherapy (LIT).
• To provide rationales for immune-based treatment of KC.

Main Methods:

• Literature review of studies on laser monotherapy and LIT for KC.
• Analysis of evidence for immune cell infiltration, tumor reduction, and systemic adaptive immunity.
• Evaluation of therapeutic potential for local and metastatic disease.

Main Results:

• Laser monotherapy can induce immune cell infiltration, tumor reduction, and resistance to re-inoculation.
• Laser immunotherapy (LIT) potentiates immune activation and anti-tumor effects.
• LIT demonstrates systemic adaptive immunity, preventing recurrence and causing regression of distant tumors.

Conclusions:

• Laser immunotherapy (LIT) shows significant therapeutic potential for both local and metastatic keratinocyte carcinoma.
• LIT may offer a more targeted and effective approach to KC treatment by harnessing the immune system.
• Further research into LIT is warranted to expand its application in KC immunotherapy.